Description

CJC-1295 / Ipamorelin

Dual-Compound Research Peptide Blend

For Laboratory Research Use Only

Product Overview

CJC-1295 / Ipamorelin  is a dual-compound research peptide formulation supplied exclusively for scientific and laboratory investigation. This combination is commonly utilized in controlled research environments for receptor interaction modeling and peptide signaling pathway studies.

Powerhaus Peptides provides this formulation in high-purity lyophilized form, manufactured under strict quality control standards to support structured laboratory protocols and experimental consistency.

Product Specifications

• Compounds:  CJC-1295 / Ipamorelin
• Format: Lyophilized Powder
• Purity: ≥ 98% (HPLC Verified, individual components)
• Quantity: 10mg blended vial (e.g., 5mg / 5mg ratio unless otherwise labeled)
• Storage: Store refrigerated (2–8°C)
• Stability: Stable under recommended laboratory storage conditions
• Batch Tracking: Yes
• Each vial is clearly labeled for laboratory identification and traceability.
• Quality Standard

Every vial undergoes:

• Third-party purity verification

• Controlled lyophilization process

• Batch-level traceability

• Laboratory-grade sealing and packaging

• Strict handling and manufacturing protocols

Powerhaus Peptides maintains elevated standards across all single and multi-compound research formulations.

Intended Use

This product is intended strictly for:

• In-vitro laboratory research
• Peptide receptor interaction studies
• Cellular signaling pathway analysis
• Controlled experimental applications
• Transition Peptides makes no claims regarding therapeutic, diagnostic, medical, or performance outcomes.

Disclaimer

• This product is for research use only.
• Not for human consumption.
• Not for medical, veterinary, or diagnostic use.
• Not for use in food, drug, cosmetic, or household applications.
• By purchasing, customers acknowledge that this material is intended solely for use by qualified professionals operating within controlled laboratory environments.